Keena S Thomas Selected Research

Keena S Thomas Research Topics

9	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2002
6	Neoplasms (Cancer) 01/2021 - 11/2003
1	Carcinoma (Carcinomatosis) 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Colitis 01/2019
1	Adenocarcinoma 11/2011
1	Necrosis 11/2011
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011
1	Inflammation (Inflammations) 02/2011
1	Fibrosarcoma 04/2002

5	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 07/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2007
3	Tamoxifen FDA LinkGeneric 11/2008 - 07/2006
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018 - 11/2011
1	Messenger RNA (mRNA)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamideIBA 11/2011
1	Gemcitabine FDA Link 11/2011
1	CollagenIBA 11/2011
1	Growth Factor ReceptorsIBA 02/2011
1	IntegrinsIBA 02/2011
1	Pharmaceutical PreparationsIBA 11/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008
1	Estrogen ReceptorsIBA 07/2007
1	ErbB Receptors (EGF Receptor)IBA 07/2006
1	STAT5 Transcription FactorIBA 07/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2005
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2003
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2003
1	LDL Receptors (LDL Receptor)IBA 11/2003
1	Epidermal Growth Factor (EGF)IBA 04/2002

1	Therapeutics 11/2011
1	Drug Therapy (Chemotherapy) 11/2008